Quintrio
Home

LABORATORY APPARATUS & FURNITURE

Kewaunee Scientific Corp

KEQU

Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Its products include steel and wood casework, fume hoods, adaptable modular systems, movable workstations, stand-alone benches, biological safety cabinets, epoxy resin work surfaces, and sinks. The company operates through two reportable segments: Lab Products Group (LPG), which designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, flexible systems, work surfaces, workstations, workbenches, and computer enclosures, and the International segment.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $34.71 – $35.28
Volume 60
Market cap $101M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$101.48M
Price / earnings
12.33×
Price / book
1.35×
Price / sales
0.37×
EV / sales
0.5×
EV / EBITDA
6.34×

Profitability

Earnings per share
$2.84
Return on assets
4.68%
Return on equity
10.97%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.61×
Current ratio
2.2×
Quick ratio
1.57×
Cash ratio
0.17×

Cash flow

Price / cash flow
6.85×
Price / free cash flow
9.33×
Free cash flow
$10.88M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for KEQU, quarterly periods
Line itemQ1 FY2027 Jul 31, 2026Q4 FY2026 Apr 30, 2026Q3 FY2026 Jan 31, 2026Q2 FY2026 Oct 31, 2025Q1 FY2026 Jul 31, 2025Q4 FY2025 Apr 30, 2025Q3 FY2025 Jan 31, 2025Q2 FY2025 Oct 31, 2024
Revenue$66.32M$71.4M$69.4M$70.1M$71.1M$77.15M$67.17M$47.76M
Cost of revenue$46.68M$50.16M$50.85M$50.38M$50.17M$53.11M$48.79M$33.81M
Gross profit$19.64M$21.25M$18.55M$19.72M$20.93M$24.04M$18.38M$13.95M
Selling, general and administrative$0$0$0$0$0$0$0$0
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$16.48M$16.03M$15.96M$15.61M$16.12M$15.54M$16.13M$9.52M
Operating income$3.16M$5.22M$2.58M$4.11M$4.81M$8.5M$2.25M$4.43M
Interest expense-$626K-$631K-$1.11M-$1.06M-$1.06M-$1.16M-$1.14M-$442K
Income before taxes$2.56M$4.76M$1.6M$3.45M$3.92M$7.15M$1.28M$3.93M
Income taxes$717K$1.06M$528K$915K$761K$2.2M-$108K$916K
Net income$1.84M$3.69M$1.08M$2.54M$3.16M$4.95M$1.38M$3.02M
Net income attributable to common shareholders$1.71M$3.39M$692K$2.45M$3.09M$4.85M$1.35M$3.01M
EBITDA$4.75M$7.34M$4.18M$5.69M$6.36M$10.29M$3.81M$5.24M
Basic earnings per share$0.59$1.18$0.24$0.85$1.08$1.70$0.47$1.05
Diluted earnings per share$0.58$1.13$0.23$0.82$1.04$1.63$0.45$1.01

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

The Zacks Analyst Blog Highlights Salesforce, S&P Global, Intuit, Kewaunee Scientific and Key Tronic

Zacks equity research analysts published reports on five stocks on October 22, 2026. Salesforce faces macroeconomic sensitivity and competition but is extending its CRM franchise through new products. S&P Global underperformed its industry with elevated costs and debt but maintains durable franchises. Intuit significantly underperformed the software industry amid a deliberate reset toward customer acquisition and tax pricing changes. Microcap stocks Kewaunee Scientific and Key Tronic both underperformed their respective industries, facing profitability and financial challenges but supported by strategic positioning and new market opportunities.

Zacks Investment Research

Top Analyst Reports for Salesforce, S&P & Intuit

Zacks analysts published research on 12 major stocks on October 21, 2026. Salesforce maintains a balanced risk-reward profile with growth drivers from Agentforce and Data 360 offsetting macroeconomic sensitivity. S&P Global faces elevated costs and debt but benefits from recurring revenues and AI adoption. Intuit shows underperformance due to fiscal 2027 reset toward customer acquisition, though long-term growth levers remain. Microcap stocks Kewaunee Scientific and Key Tronic face profitability challenges but benefit from portfolio expansion and supply chain repositioning respectively.

Zacks Investment Research

Kewaunee Q1 Earnings Fall Y/Y Despite International Strength

Kewaunee Scientific Corporation (KEQU) reported first-quarter fiscal 2027 results with sales declining 6.7% to $66.3 million and EPS falling to $0.58 from $1.04 year-over-year. The Lab Products Group faced headwinds from challenging life sciences market conditions, though the International segment showed improved profitability through higher-margin project mix. Management remains confident in underlying demand despite extended project timelines amid geopolitical and economic uncertainty.

Benzinga

Insiders Buying Chart Industries And 2 Other Stocks

Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Ooma The Trade: Ooma, Inc. (NYSE: OOMA) CEO and President Eric ...

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Sep 9, 2019$0.19Sep 24, 2019recurring
Jun 6, 2019$0.19Jun 21, 2019recurring
Mar 8, 2019$0.19Mar 25, 2019recurring
Dec 3, 2018$0.19Dec 17, 2018recurring
Sep 10, 2018$0.19Sep 25, 2018recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.